Abbott Laboratories (ABT) Return on Capital Employed (2009 - 2026)

Abbott Laboratories has disclosed Return on Capital Employed across 18 years of filings, most recently posting 9.61% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 9.61%, down 81.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.61% (down 81.0% YoY), and the FY2025 annual result was 11.92%, up 111.0% from the prior year.
• Return on Capital Employed came in at 9.61% for Q1 2026 at Abbott Laboratories, down from 11.68% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 37.41% in Q4 2022 to a low of 9.61% in Q1 2026.
• The 5-year median for Return on Capital Employed is 11.01% (2023), against an average of 15.34%.
• Across the five-year window, Return on Capital Employed soared 669 bps in 2022 and tumbled 2639 bps in 2023, its largest moves.
• Abbott Laboratories' Return on Capital Employed stood at 37.41% in 2022, then tumbled by 71 bps to 11.01% in 2023, then fell by 3 bps to 10.71% in 2024, then gained by 9 bps to 11.68% in 2025, then slipped by 18 bps to 9.61% in 2026.
• The last three Return on Capital Employed figures came in at 9.61% (Q1 2026), 11.68% (Q4 2025), and 11.1% (Q3 2025), per Business Quant data.